Brief: Entera Bio Reports Q1 Loss Per Share Of $0.13

Entera Bio

12/05/2022 13:27

May 12 (Reuters) - Entera Bio Ltd  5DT.F :
    * ENTERA BIO REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
BUSINESS HIGHLIGHTS
    * AS OF MARCH 31, 2022, ENTERA HAD CASH AND CASH EQUIVALENTS
OF
$20.1 MILLION, COMPARED TO $24.9 MILLION AS OF DECEMBER 31, 2021
    * EXPECTS THAT CURRENT CASH IS SUFFICIENT TO FUND OPERATIONS
INTO
Q4 OF 2022
    * Q1 LOSS PER SHARE $0.13

Source text for Eikon:  ID:nGNXbhbxJ0 
Further company coverage:  5DT.F 

 ((Reuters.Briefs@thomsonreuters.com;))